Arcutis Biotherapeutics, Inc. Common Stock vs. Eli Lilly & Co.
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
$32.07 +0.31%
VS LLYEli Lilly & Co.
$1437.29 +0.35%
Arcutis Biotherapeutics, Inc. Common Stock and Eli Lilly & Co. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ARQT | LLY | |
|---|---|---|
| Market Cap | $4.03 billion | $1.28 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| ARQT | LLY | |
|---|---|---|
| Dividend Yield | — | 0.48% |
ARQT and LLY split the dividend factors evenly.
Risk & Sentiment
| ARQT | LLY | |
|---|---|---|
| Short Interest | 0.19% | 1.29% |
ARQT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ARQT overview, ARQT financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.